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Edited by Gianni CesareniAbstract Stabilin-2 was recently identiﬁed as a novel receptor
for membrane phosphatidylserine of apoptotic cells. To identify
proteins that were candidates for stabilin-2 cytoplasmic domain
binding, we screened a human spleen cDNA library using the
yeast two-hybrid system. We found that thymosin b4 interacts
with the stabilin-2 cytoplasmic domain and is co-localized with
stabilin-2 at the phagocytic cup. Knockdown of thymosin b4 sig-
niﬁcantly decreased the phagocytic activity of stabilin-2, whereas
overexpression of thymosin b4 increased this activity. Addition-
ally, amino acids 2504–2514 of stabilin-2 cytoplasmic domain
were found to be responsible for the interaction with thymosin
b4. Taken together, these results suggest that thymosin b4 is a
downstream molecule of stabilin-2 that plays a role in stabilin-
2-mediated cell corpse clearance.
Structured summary:
MINT-6542321, MINT-6542357:
Stab2-c (uniprotkb:Q8WWQ8) physically interacts (MI:0218)
with tb4 (uniprotkb:P20065) by anti tag coimmunoprecipitation
(MI:0007)
MINT-6542368:
Stab2-c (uniprotkb:Q8WWQ8) physically interacts (MI:0218)
with tb4 (uniprotkb:P20065) by pull down (MI:0096)
MINT-6542300:
Stab2-c (uniprotkb:Q8WWQ8) physically interacts (MI:0218)
with tb4 (uniprotkb:P62328) by two hybrid (MI:0018)
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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hybrid analysis1. Introduction
Stabilin-2/FEX-2/FEEL-2/HARE, which was initially iden-
tiﬁed as a rat hepatic hyaluronic acid receptor, has also been
identiﬁed as an endocytic receptor for hyaluronic acid in hepa-Abbreviations: PS, phosphatidylserine; RBCs, red blood cells; LDL,
low-density lipoprotein; AGE, advanced glycation end; GST, gluta-
thione S-transferase; GFP, green ﬂuorescent protein; siRNA, small
interfering RNA; FITC, ﬂuorecein-5-isothiocyanate; DIC, diﬀerential
interference contrast; ILK, integrin linked kinase; ABPs, actin-binding
proteins
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doi:10.1016/j.febslet.2008.03.058tic sinusoidal endothelial cells [1]. Stabilin-2 exhibits a unique
structural feature that consists of seven fasciclin domains, 23
epidermal growth factor-like domains, a membrane proximal
link domain, and a single transmembrane domain followed
by a short c-terminal cytoplasmic tail. The overall architectural
feature of stablin-2 deﬁnes it as a type I transmembrane pro-
tein [2]. Previous studies had demonstrated that stabilin-2
plays a role as a multifunctional scavenger receptor that medi-
ates endocytic removal of ligands such as acetylated low-den-
sity lipoprotein (LDL), bacterial bioparticles and advanced
glycation end (AGE) products [3].
In a previous study, we demonstrated that stabilin-2 also
functions as a membrane receptor involved in the engulfment
of apoptotic cells [4]. Stabilin-2 can stereospeciﬁcally recognize
phosphatidylserine (PS). In addition, activation of stabilin-2
results in the release of an anti-inﬂammatory cytokine, TGF-
b, by macrophages, which suggests that stabilin-2 is a bona ﬁde
PS-receptor for cell corpse clearance in macrophages.
Although stabilin-2 has a short cytoplasmic domain, it is sup-
posed to be responsible for the signal transduction that enables
the phagocytic function of stabilin-2 [5]. In this study, we
screened a human spleen cDNA library using the yeast two-hy-
brid system to identify stabilin-2 cytoplasmic domain binding
proteins. When the stabilin-2 cytoplasmic domain was used
as bait, thymosin b4 (TMSB4X, NM_021109) was identiﬁed
as one of the candidate binding proteins.
Thymosin b4, which is a 43-amino acid peptide present in
nearly all mammalian cells, is involved in actin sequestering
and the promotion of cell migration [6]. Actin is essential for
cell division, cell movement, phagocytosis and diﬀerentiation.
In addition, the central actin-binding site in thymosin b4 is re-
quired for its angiogenic [7] and wound-healing activity [8,9],
suggesting that its interaction with actin is functionally impor-
tant beyond sequestration [10].
Biochemical analyses such as in vitro direct binding of gluta-
thione S-transferase (GST)-pull down, co-immunoprecipita-
tion assays and immunoﬂuorescence images were also
conducted to conﬁrm that thymosin b4 interacts with the sta-
bilin-2 cytoplasmic domain. Thymosin b4 knockdown by small
interfering RNA (siRNA) signiﬁcantly reduced the phagocyto-
sis of aged red blood cells (RBCs) in stabilin-2 transfectants. In
addition, live imaging of thymosin b4-GFP in stabilin-2-med-
iated phagocytosis showed that it participated in the phago-
cytic process. Taken together, the results of this study
provide new evidence that thymosin b4 regulates stabilin-2-
mediated phagocytosis of aged RBC and participates in the
early stages of phagocytosis by interacting with the stabilin-2
cytoplasmic domain.ation of European Biochemical Societies.
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2.1. Cell culture
L cells (mouse ﬁbroblastic cell line), which were kindly donated by
Dr. M. Takeichi in the Department of Biophysics, Faculty of Science,
Kyoto University, Japan, were grown in Dulbeccos Modiﬁed Eagle
Medium (DMEM) (Life Technologies, Gaithersburg, MD) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS) and anti-
biotics (Life Technologies Inc., Grand Island, NY, USA) at 37 C
under 5% CO2. L cells that stably expressed stabilin-2-myc (L/Stab-
2) were established previously [14] and maintained in DMEM contain-
ing 0.4 mg/ml G418 (Invitrogen, Carlsbad, CA, USA).2.2. DNA constructs
DNA constructs used to create GST-fusion proteins of the stabilin-2
cytoplasmic domain were generated using speciﬁc primers designed to
produce PCR products that corresponded to the stabilin-2 cytoplasmic
domain (FL: amino acids from 2481 to 2551, D1: deletion of 2496–2551
amino acids, D2: deletion of 2504–2551 amino acids and D3: deletion
of 2515–2551 amino acids). After ampliﬁcation of the stabilin-2 cDNA
the PCR products were subcloned into the BamHI and XhoI sites of
pGEX-5X3 vector (FL, D1, D2 and D3 forward primer-GTG GGA
TCC CCT CCT ACC GGA TA; full length reverse primer-TGC
TCG AGC AGT GTC CTC AAG GG, D1 reverse primer-TGC
TCG AGA AAA TGC TGG AAG CC, D2 reverse primer-TGC
TCG AGA TTA ATG TCC TCT TCC GA, D3 reverse primer-TGC
CGAGGT GTG TCT ATA AC) (Amersham Biosciences, Piscataway,
NJ). GFP-Thymosin b4 was produced by subcloning the PCR prod-
ucts that contained the relevant cDNA (Tmsb4x, NM_021278) into
the BglII/HindIII site in the multiple cloning site of pEGFP-N1 vector
(forward primer, AGA TCT ATG TCT GAC AAA CCC GAT ATG
G; reverse primer, AAG CTT GCG ATT CGC CAG CTT GCT TC)
(Clontech, Palo Alto, CA).2.3. Yeast two-hybrid assay
To screen for stabilin-2 binding protein in human spleen cells, a
yeast two-hybrid assay was performed using the Matchmaker Gal4
two-hybrid system (Clontech) according to the protocols provided by
the manufacturer. Brieﬂy, the PCR product of the stabilin-2 cytoplas-
mic domain (2481–2551 amino acids) was cloned into the EcoRI/Bam-
HI sites of the yeast bait vector, pGBKT7 (forward primer, CCGGAA
TTC GGA GCA GGG ATC TTC TTT; reverse primer, CGC GGA
TCC TCA CAG TGT CCT CAA GGG). A human spleen cDNA li-
brary (Matchmaker, Clontech) was then screened as prey. Next, the
recovered plasmids were transformed into yeast strain AH190 using
the lithium acetate method. The co-transformants were then selected
for by plating the samples onto minimum medium lacking SD/-His/
-Leu/-Trp and then incubating them at 30 C for 3–5 days. The
b-galactosidase activity was then evaluated using a ﬁlter lift assay, with
pGBKT7-53/pGADT7-T and pGKT7-Lam provided by the manufac-
turer being used as positive and negative controls. Next, plasmid DNA
was extracted from positive yeast clones and transformed into Esche-
richia coli for the selection of the ‘‘prey’’ plasmids, which were then
analyzed by restriction digestion (identiﬁcation of multiple identical
clones) and by sequence analysis using vector insert screening ampliﬁ-
ers. The homology of the products was then evaluated using BLAST
searches of the GenBank database.2.4. Phagocytosis assay
Aged RBCs were prepared from fresh human blood obtained from
healthy donors. Brieﬂy, the anti-coagulated blood was sedimented over
Ficoll-PaqueTM Plus (Amersham Biosciences, Uppsala, Sweden) and
then centrifuged at 400 · g for 30 min at 15 C. The samples were then
washed twice with sterilized phosphate-buﬀered saline (PBS), after
which, the RBCs at a hematocrit level of 20% were incubated at
37 C under 5% CO2 for 4 days. L/Stab-2 cells were then incubated
with aged RBCs at a hematocrit level of 1% in complete medium
and then incubated for 1 h at 37 C. The cells were then extensively
washed with PBS and exposed to H2O for 10 s to induce hypotonic
lysis of the RBCs that were bound to the cell surface. Next, the cells
were stained with Diﬀ-Quik solution (International Reagen Corp.,
Kobe, Japan) and the number of cells that contained ingested RBCs
was then determined by evaluating 10 randomly selected ﬁelds. Theresults are expressed as the phagocytic index (%), which was calculated
by multiplying the percentage of phagocytosing cells by the average
number of ingested RBCs per phagocytosing cell [11].2.5. Immunoﬂuorescence microscopy
L/Stab-2 cells were placed on a coverslip and then incubated with
ﬂuorecein-5-isothiocyanate (FITC)-labeled aged RBCs (15–20 lg/ml
FITC) at a concentration of 1% hematocrit in complete medium for
1 h at 37 C under 5% CO2. The cells were then extensively washed
with PBS and exposed to H2O for 10 s to lyse the uningested RBCs.
The cells that grew on the coverslips were then ﬁxed with 4% parafor-
maldehyde in PBS, after which the coverslips were treated with a solu-
tion containing 0.1% Triton X-100 in PBS for 10 min to permeabilize
the cells. The coverslips were then blocked with a PBS solution con-
taining 0.1% Triton X-100 and 2% BSA for 1 h. Next, the cells on
the coverslip were washed with PBS and then incubated with mouse
monoclonal anti-c-myc antibody (cell signaling, 1:2000) and rabbit
polyclonal anti-thymosin b4 (Abcam Inc, Cambridge, MA, 1:200).
After brief PBS rinses, the cells were incubated for 1 h in the dark with
1:1000 dilution of goat anti-rabbit conjugated to Alexa Fluor 568
(Invitrogen Corporation), and goat anti-mouse IgGs conjugated to
Alexa Fluor 647. The F-actin in the cells was then labeled with
FITC-phalloidin (Molecular Probes, Inc., Eugene, OR) and the cellu-
lar ﬂuorescence was analyzed by confocal microscopy using a Leica
DMIRB microscope equipped with ﬂuorescence and transmitted light
optics. The obtained images were then analyzed using Metamorph ver-
sion 7.1 (Universal Imaging Corp.).2.6. Live cell imaging and image analysis
L/Stab-2 cells expressing GFP-thymosin b4 were added to collagen-
coated LabTek chambers. After aged RBC treatment, the individual
live cells were monitored by time-lapse confocal microscopy imaging,
with images being taken at 10 s intervals. The images were then ana-
lyzed using Metamorph version 7.1 (Universal Imaging Corp.).2.7. Co-immunoprecipitation and immunoblotting
Stably transfected L/Stab-2 cells were lysed in lysis buﬀer (50 mM
Tris–Hcl, 150 mM NaCl, 1% Triton X-100, 10 mM sodium ﬂouride,
1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 1 mM
PMSF, 10 lg/ml pepstatin, 10 lg/ml leupeptin, and 10 lg/ml aproti-
nin). The samples were then centrifuged at 12000 rpm for 5 min at
4 C. The supernatants (1 mg of total protein) were then collected
and incubated with 50 ll of myc-agarose beads (Sigma) overnight at
4 C. The beads were then washed extensively with lysis buﬀer, after
which the bound proteins were eluted by boiling in 2 · SDS sample
buﬀer for 10 min. The sample proteins were then separated by SDS–
PAGE on 6% and 15% gels and immunoblotted with anti-c-myc and
anti-thymosin b4 antibodies, respectively.
The separated proteins were then transferred to nitrocellulose mem-
brane (Schleicher and Schuell BioScience GmbH, Dassel, Germany),
which was blocked with 5% skim milk in Tris-buﬀered saline (TBS)
buﬀer (136 mM NaCl, 25 mM Tris–Cl, 2.6 mM KCl, pH 7.4) for 2 h
at room temperature before incubation with anti-c-myc and anti-thy-
mosin b4 antibodies in TBS-T buﬀer (TBS containing 0.1% (v/v)
Tween-20) overnight at 4 C. The membrane was then washed with
TBS-T buﬀer three times for 10 min each and incubated with horserad-
ish peroxidase (HRP)-conjugated donkey anti-rabbit IgG (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) for 1 h at room temperature. The
immunoreactive bands in the membrane were then detected using ECL
solution (Amersham Bioscience, Buckinghamshire, UK).2.8. siRNA for thymosin b4
The sequences of thymosin b4 siRNA used in this study were re-
ported by Smart et al. [12]. Brieﬂy, the following oligonucleotides were
synthesized by Bioneer corp. (Korea): 5-CTGAGATCGA-
GAAATTCGATAAG -3 (Tb4 siRNA1, sense strand); FITC-labeled
5-AGAAGCAAGCTGGCGAATCGTAA-3 (Tb4, siRNA2, sense
strand). The oligonucleotides were then annealed by heating them to
90 C in the presence of 50 mM NaCl and then gradually cooling them
to room temperature. Cells were then transfected with the siRNA du-
plex using HiPerFect Transfection Reagent (QIAGEN, CA, SA)
according to the manufacturers instructions. Following transfection
for 24 h, cells were recovered in complete medium and phagocytosis as-
Fig. 1. Thymosin b4 interacts with the cytoplasmic domain of stabilin-2
(FEX2c) and is co-immunoprecipitated with stabilin-2 and vice versa.
(A) Schematic representation of the stabilin-2 cytoplasmic domain
used as bait in yeast two-hybrid screening. The critical amino acids
S.-J. Lee et al. / FEBS Letters 582 (2008) 2161–2166 2163says were conducted in duplicate plates. The statistical signiﬁcance was
then assessed by ANOVA, with a P < 0.01 being considered to be sta-
tistically signiﬁcant.
2.9. Puriﬁcation of GST-fusion proteins and pull-down assay
For puriﬁcation of the GST-fusion proteins of the stabilin-2 cyto-
solic domain deletion constructs, BL21 cells transformed with the plas-
mids were induced by incubation with 0.1 M IPTG overnight at 30 C.
After induction, the harvested cells were suspended in PBS and then
brieﬂy sonicated. To ensure complete lysis of the cells, 1% Triton X-
100 was added to the bacterial suspensions and the samples were then
incubated for 1 h at 4 C. The lysates were then cleared by centrifuga-
tion at 10000 · g for 10 min at 4 C, after which the supernatant was
removed, mixed with glutathione-sepharose 4B beads (Amersham Bio-
sciences, Piscataway, NJ) and incubated for 1 h at 4 C. The beads
were then washed three times with PBS and stored at 80 C. For
the GST pull-down assay, the cell lysates from stably transfected L
cells that constitutively expressed a high level of stabilin-2 were pre-
pared in PBSC buﬀer (PBS containing 1% Nonidet P-40, 1 mM CaCl2,
0.5 mM MgCl2, 1 mM PMSF, 5 lg/ml aprotinin, 0.1 mM NaVO4), as
described previously [13]. GST and GST-fusion proteins of stabilin-2
mutants bound to glutathione sepharose beads (50 lg) were then incu-
bated with 1 mg of cell lysates overnight at 4 C. The cell lysates were
then washed with PBSC buﬀer three times, after which the proteins
bound to beads were eluted by boiling in 2 · SDS-sample buﬀer. The
proteins were then separated by 6% SDS–PAGE and immunoblotted
with anti-stabilin-2 antibody.from 2481 to 2551 in the stabilin-2 cytoplasmic domain contain the
YxxU motif, the ESEED acidic cluster and the NPXY motif
(underlines). (B) An interaction between the thymosin b4 and
stabilin-2 cytoplasmic domain induces the expression of b-galactosi-
dase, which is detected as a blue color in the ﬁlter lift assay. pGBKT7-
53/pGADT7-T and pGKT7-Lam provided by the manufacturer were
used as the positive and negative controls, respectively. (C) L/Stab-2
cells that co-expressed myc-tagged stabilin-2 and endogenous thymosin
b4 were subjected to immunoprecipitation by antibodies against either
anti-c-Myc (upper panel) or anti-thymosin b4 (lower panel). Stabilin-2
from cell lysates was immunoprecipitated with anti-c-myc antibody.
Next, the immunoprecipitated proteins were separated by 6% and 15%
SDS–PAGE and then immunoblotted with anti-stabilin-2 and anti-
thymosin b4 antibodies, respectively. The results shown here are
representative of three independent experiments.3. Results
3.1. Thymosin b4 interacts with the cytoplasmic domain of
stabilin-2
A yeast two-hybrid assay was performed to identify proteins
that interact with the cytoplasmic domain of stabilin-2
(Fig. 1A). The results of this assay identiﬁed several candidate
proteins (data not shown). The protein interactions, which
were indicated by growth on selective media, were then con-
ﬁrmed by assessing the relative expression of b-galactosidase
by the lacZ reporter gene using an X-gal ﬁlter assay. One of
the identiﬁed proteins was thymosin b4 (TMSB4X,
NM_021109) (Fig. 1B). Interestingly, the amino acid sequence
of the isolated human thymosin b4 shared 100% homology
with that of mouse thymosin b4. An immunoprecipitation as-
say was then performed to further conﬁrm the interaction be-
tween the cytoplasmic domain of stabilin-2 and thymosin b4.
As shown in Fig. 1C, stabilin-2 was co-immunoprecipitated
with thymosin b4 and vice versa, however, it was not co-pre-
cipitated with the control IgG-conjugated bead. Taken to-
gether, these results indicate that thymosin b4 interacts with
stabilin-2 in vitro.3.2. Thymosin b4 is co-localized with stabilin-2, involved in the
formation of phagocytic cups and involved in the
internalization of aged RBCs during phagocytosis
Phagocytosis requires actin polymerization, which causes
dynamic membrane remodeling that results in membrane ruf-
ﬂing, the formation of pseudopods and phagosome maturation
[14]. Thymosin b4 and F-actin accumulated at the phagocytic
cup formed on the surface of L/Stab-2 cells (Fig. 2A). There-
fore, immunocytochemistry was used to determine if thymosin
b4 and stabilin-2 were co-localized during the phagocytosis
process. Triple-labeled ﬂuorescent images demonstrated that
thymosin b4 and stabilin-2 were enriched around FITC-la-
beled aged RBCs (Fig. 2B). In addition, the merged image re-
vealed that thymosin b4 and stabilin-2 were co-localizedduring the phagocytic process of L/Stab-2 cells. As shown in
Fig. 2C, orthogonal projection of the confocal slices demon-
strated that aged RBCs were detected within the L/Stab-2 cells.
Next, we transfected a cDNA that encoded GFP-thymosin b4
fusion protein into L/Stab-2 cells to conﬁrm the localization of
thymosin b4 during stabilin-2-mediated phagocytosis. We then
used phase-contrast, confocal microscopy and video recording
to study the phagocytosis of aged RBCs by L/Stab-2 cells.
GFP-thymosin b4 was found to be distributed uniformly
throughout the cytoplasm, but was concentrated in some ruf-
ﬂes and lamellipodia (data not shown). In addition, GFP-thy-
mosin b4 was redistributed to the phagosome of L/Stab-2 cells
after 0–19 min and then mostly cleared after 28 min (Fig. 3,
upper panel, Movie 1). The phase-contrast and GFP merge
images showed multiple phagocytic events in L/Stab-2 cells
(Fig. 3, lower panel). After the aged RBCs were completely
internalized, thymosin b4 was released from the phagosome.
Taken together, these results suggest that GFP-thymosin b4
fusion protein is involved in the formation of early phagocytic
cups and the internalization of aged RBCs.
3.3. Thymosin b4 is required for stabilin-2-mediated
phagocytosis
After establishing the interaction between stabilin-2 and
thymosin b4, we investigated the role of thymosin b4 in
Fig. 2. L/Stab-2 cell showing the co-localization of thymosin b4
around aged RBCs during phagocytosis. (A) Thymosin b4 accumu-
lates at the phagosomes (arrow head). L/Stab-2 cells were incubated
with aged RBCs in complete medium and then incubated for 1 h at
37 C. Next, the cells were ﬁxed, permeabilized and stained with anti-
thymosin b4 antibody (red) and FITC-phalloidin (green). (B) L/Stab-2
cells were incubated with FITC-labeled aged RBCs (green) in complete
medium and then incubated for 1 h at 37 C. Confocal pictures show
that L/Stab-2 cells were double stained for thymosin b4 (red) and
stabilin-2 (yellow). Merged images show that the co-localization of
thymosin b4 and stabilin-2 occurred primarily around aged RBCs
(arrows). (C) Orthogonal projections of confocal images show that
aged RBCs (green) are engulfed by L/Stab-2 cells (red). Pixels with
both red and yellow signals appear orange. Bar. 10 lm.
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transfected with stabilin-2 showed signiﬁcantly increased levels
of endogenous thymosin b4 proteins when compared with the
parent L cells (data not shown). Next, siRNA was used to
knockdown the expression of thymosin b4 in L/Stab-2 cells
(Fig. 4A). The siRNA used was speciﬁcally designed to beFig. 3. Distribution of GFP-Thymosin b4 during phagocytosis. Upper panel
of GFP-thymosin b4. The aged RBC binding is indicated by the arrow head
shows aged RBC binding and engulfment. Engulfed aged RBCs are indicate
using Metamorph software. Bar. 10 lm.functional in two target sequences [12]. L/Stab-2 cells transfec-
ted with FITC-labeled siRNA were then evaluated using ﬂuo-
rescence microscopy (data not shown), which revealed that the
target cells were successfully transfected with the siRNA.
Immunoblotting with anti-thymosin b4 antibody showed sig-
niﬁcantly reduced thymosin b4 expression in siRNA transfec-
ted cells when compared with control transfectants (Fig. 4B).
In addition, a phagocytosis assay, which was performed using
aged RBCs to evaluate the eﬀect of thymosin b4 silencing on
the phagocytic function of L/Stab-2 cells, revealed that greater
than 50% inhibition occurred in siRNA transfected L/Stab-2
cells (Fig. 4C). Cells transfected with control siRNA did not
show any alterations in the phagocytosis index. Taken to-
gether, these results indicate that thymosin b4 is signiﬁcantly
involved in the process of phagocytosis. To further investigate
the functional link between stabilin-2 and thymosin b4, we
used an alternative approach in which the eﬀects of over-
expressing thymosin b4 in cells that expressed stabilin-2 were
observed. Overexpression of thymosin b4 increased the uptake
of aged RBCs by 15% in L/Stab-2 cells when compared to
cells transfected with a control (Fig. 4D). These results corrob-
orate our ﬁndings that thymosin b4 is required for stabilin-2-
mediated phagocytosis.
3.4. Amino acids from 2504 to 2514 of stabilin-2 are required for
thymosin b4 binding
In order to identify the cytoplasmic domain that is responsi-
ble for binding thymosin, four GST-stabilin-2 deletion pro-
teins (FL: amino acids from 2481 to 2551, D1: deletion of
2496–2551 amino acids, D2: deletion of 2504–2551 amino acids
and D3: deletion of 2515–2551 amino acids) were puriﬁed
(Fig. 5A). As shown in Fig. 5B, the GST-stabilin-2 constructs
that contained the full length and D3 proteins were able to co-
precipitate with thymosin b4, but the GST-stabilin-2 con-
structs that contained the D1 and D2 proteins did not. These
results indicate that amino acids 2504–2514 of stabilin-2 are
responsible for the interaction with thymosin b4.4. Discussion
The clearance of aged RBCs and apoptotic cells occurs
throughout the lifespan of multicellular organisms and is, time-lapse confocal microscopy image series show ﬂuorescence images
. Lower panel, overlay images of GFP and DIC are shown. Red arrow
d by the white arrow. Images were taken at 5 s intervals and analyzed
Fig. 4. Thymosin b4 overexpression or knockdown aﬀects stabilin-2-mediated phagocytosis. (A) siRNAs were speciﬁcally designed to be functional
in two target sequences of the a-helix (Tb4-siRNA1) and c-terminal region of thymosin b4 (Tb4-siRNA2). (B) Expression of thymosin b4 in thymosin
b4 siRNA-treated cells. At 48 h post transfection with siRNA, cells were harvested and analyzed by Western blot. (C) The inhibition of aged RBC
engulfment by thymosin b4-siRNA (Tb4-siRNA#) and control siRNA pretreatment. The percentages of cells engulﬁng aged RBCs were determined.
(D) Overexpression of thymosin b4 enhances the engulfment of aged RBCs in L/Stab-2 cells. The results are expressed as the means ± S.D. from at
least three experiments. ANOVA, *P < 0.01.
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maintenance of tissue integrity and function, and the resolu-
tion of inﬂammation. We previously demonstrated that stabi-
lin-2 can speciﬁcally recognize phosphatidylserine in apoptotic
cells, which enables it to mediate their engulfment [4]. Down-
stream signal transducing molecules, however, have not been
identiﬁed in stabilin-2-mediated phagocytosis. Therefore, we
performed a yeast two-hybrid analysis using the stabilin-2
cytoplasmic domain as bait for the screening of a human
spleen cDNA library in an attempt to identify adaptor mole-
cules. The results of this study demonstrated that thymosin
b4 speciﬁcally interacts with the cytoplasmic domain of stabi-
lin-2 and is co-localized with F-actin and stabilin-2 in the
phagocytic cups. In addition to this biochemical interaction,
down-regulation by siRNA was shown to signiﬁcantly inhibit
the stabilin-2-mediated phagocytosis, whereas overexpression
was found to enhance phagocytosis, which suggests that thy-
mosin b4 acts as a downstream molecule of stabilin-2 and
mediates phagocytosis of apoptotic cells.
The ‘‘tether’’ (recognition of PS) and ‘‘tickle’’ (internaliza-
tion of apoptotic cells and activation of downstream signaling
pathways) mechanisms are required for the clearance of apop-
totic cells [15], and it has been suggested that stabilin-2 exerts
both these functions and can tether and tickle apoptotic cells
alone [4]. However, in this study, thymosin b4 was not local-
ized where the aged RBCs bind, but was localized in the area
in which the phagocytic cups are formed. Taken together,
these results suggest that thymosin b4 is involved in the tick-
ling step of phogocytosis mediated by stabilin-2.Cytoskeletal rearrangement is known to be tightly associated
with the dynamic process of phagocytosis [16], and the dy-
namic regulation of the actin cytoskeleton is tightly controlled
by diverse actin-binding proteins (ABPs) such as thymosin b4
[17]. However, thymosin b4 has not yet been reported to be in-
volved in phagocytosis. Nevertheless, the high concentrations
of thymosin b4 in the G-actin pool participate in actin depoly-
merization [18], which suggests that thymosin b4 may play a
role in the depolymerization of the actin skeleton and is in-
volved with the completion of engulfment. Our time-lapse im-
age of phagocytosis shows that upon internalization of RBCs,
thymosin b4 is released from the phagosome. However, a more
deﬁned time-lapse imaging study should be conducted to better
understand this phenomenon. Alternatively, thymosin b4 may
bring the actin molecule to the site at which engulfment takes
place. The actin molecule may be released when thymosin b4
binds to the cytoplasmic domain of stabilin-2. Then, free actin
is to be polymerized where engulfment takes place. This study
is the ﬁrst to show that thymosin b4 is involved in phagocyto-
sis; however, the exact role that thymosin b4 plays in this pro-
cess is unclear. Interestingly, stabilin-2 expressing stable cell
clones showed a signiﬁcantly increased level of endogenous
thymosin b4 expression when compared with parent L cells
(data not shown), and thymosin b4 is known to be present
in high concentrations in peritoneal macrophages [19].
In addition to interaction with G-actin, thymosin b4 has
been reported to interact with other molecules including
PPP4C (protein phosphatase 4 catalytic subunit) [20] and
PINCH [21]. We found that the amino acids 2504–2514 in
Fig. 5. Amino acids from 2504 to 2514 of stabilin-2 are required for
thymosin b4 binding. (A) Schematic diagram of the cytoplasmic tail of
stabilin-2 fused to GST. (B) SDS–PAGE and Coomassie staining of
GST-Stabilin-2 constructs (left). GST-stabilin-2 fusion protein or GST
alone bound to glutathione sepharose beads (50 lg) were incubated
overnight at 4 C with cell lysates prepared from L/Stab-2 cells. The
beads were then extensively washed, after which the bound proteins
were separated by SDS–PAGE on a 15% gel and immunoblotted with
anti-thymosin b4 antibody (right). The input lane was loaded with 20%
of the total cell lysates. The results shown are representative of three
experiments.
2166 S.-J. Lee et al. / FEBS Letters 582 (2008) 2161–2166stabilin-2 are required for interaction with thymosin b4; how-
ever, this region does not have a common signature motif
found in other eﬀector molecules. Although the C-terminal re-
gion of PINCH is known to interact with thymosin b4, it does
not share a common sequence with amino acids 2504–2514 of
stabilin-2.
In conclusion, the results of this study demonstrate that thy-
mosin b4 is a downstream molecule of stabilin-2 that can inter-
act with its cytoplasmic domain. In addition, these results
indicate that thymosin b4 plays a role in stabilin-2-mediated
phagocytosis of apoptotic cells. However, the exact role that
thymosin b4 plays in phagocytosis remains to be elucidated.
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